Recombinant SLC34A2 (Lifastuzumab Biosimilar) antibody
The Mammalian Cells Monoclonal anti-SLC34A2 (Lifastuzumab Biosimilar) antibody has been validated for not_set. It is suitable to detect SLC34A2 (Lifastuzumab Biosimilar) in samples from Human.
Catalog No. ABIN7488029
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 8 Business Days
Quick Overview for Recombinant SLC34A2 (Lifastuzumab Biosimilar) antibody (ABIN7488029)
Target
SLC34A2 (Lifastuzumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Conjugate
This SLC34A2 (Lifastuzumab Biosimilar) antibody is un-conjugated
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Lifastuzumab Biosimilar - Anti-SLC34A2 mAb
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS buffer pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- SLC34A2 (Lifastuzumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
- DNIB0600A (conjugate),MNIB2126A (non conjugate)
Target
-
You are here:
